HMGA1 Interacts with β-Catenin to Positively Regulate Wnt/β-Catenin Signaling in Colorectal Cancer Cells

Pathology and Oncology Research

Volumn 20, Issue 4, 2014, Pages 847-851

  Xing, Junjie ^a   Cao, Guangwen ^b   Fu, Chuangang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; HMGA1; Wnt signaling pathway; catenin

Indexed keywords

EID: 84897199922     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-014-9763-0     Document Type: Article

References (19)

1. Fusco A, Fedele M (2007) Roles of HMGA proteins in cancer. Nat Rev Cancer 7:899–910
2. Shah SN, Kerr C, Cope L et al (2012) HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. PLoS One 7:e48533
3. Di Cello F, Shin J, Harbom K, Brayton C (2013) Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice. Biochem Biophys Res Commun 434:70–74
4. Chiappetta G, Ottaiano A, Vuttariello E et al (2010) HMGA1 protein expression in familial breast carcinoma patients. Eur J Cancer 46:332–339
5. Takeuchi I, Takaha N, Nakamura T et al (2012) High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells. Prostate 72:1124–1132
6. Pang B, Fan H, Zhang IY et al (2012) HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis. J Neurooncol 106:543–549
7. Hillion J, Smail SS, Di Cello F et al (2012) The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma. Pancreatology 12:372–379
8. Nezhad MH, Drieschner N, Helms S et al (2010) 6p21 rearrangements in uterine leiomyomas targeting HMGA1. Cancer Genet Cytogenet 203:247–252
9. Bush BM, Brock AT, Deng JA, Nelson RA Jr, Sumter TF (2013) The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer. Cell BiochemFunct 31:228–236
10. Zhang Y, Ma T, Yang S et al (2011) High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells. Mol Cell Biochem 357:363–371
11. Clevers H, Nusse R (2012) Wnt/β-catenin signaling and disease. Cell 149:1192–1205
12. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9–26
13. Rosenbluh J, Nijhawan D (2012) Cox AG: β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151:1457–1473
14. Akaboshi S, Watanabe S, Hino Y et al (2009) HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer. Am J Pathol 175:1675–1685
15. Konsavage WM Jr, Kyler SL, Rennoll SA, Jin G, Yochum GS (2012) Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem 287:11730–11739
16. Guo RJ, Funakoshi S, Lee HH, Kong J, Lynch JP (2010) The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex. Carcinogenesis 31:159–166
17. Emami KH, Nguyen C, Ma H et al (2004) A small molecule inhibitor of beta-catenin/CREB-binding protein transcription. Proc Natl Acad Sci U S A 101:12682–12687
18. Shah SN, Resar LM (2012) High mobility group A1 and cancer: potential biomarker and therapeutic target. Histol Histopathol 27:567–579
19. Giannini G, Cerignoli F, Mellone M, Massimi I, Ambrosi C, Rinaldi C, Gulino A (2005) Molecular mechanism of HMGA1 deregulation in human neuroblastoma. Cancer Lett 228:97–104